Trials / Completed
CompletedNCT04286009
Pathogenesis and Mechanisms of Mitral Annular Calcification
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
Researchers are testing blood or mitral valve tissue to better understand the reasons why Mitral Annular Calcification (MAC) develops in patients with heart disease.
Detailed description
The aim is to test the hypothesis that Endothelial Progenitor Cells osteoblastic phenotype (EPC-OCNs) play a significant role in the process of Mitral Annular Calcification (MAC) as prognostic markers of calcific cardiac valves.
Conditions
Timeline
- Start date
- 2020-07-28
- Primary completion
- 2024-04-01
- Completion
- 2024-04-01
- First posted
- 2020-02-26
- Last updated
- 2024-07-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04286009. Inclusion in this directory is not an endorsement.